Need professional-grade analysis? Visit stockanalysis.com
$319.13M
N/A
80
N/A
Amarin Corporation PLC (AMRN) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at $14.98, up 1.77% from the previous close.
Over the past year, AMRN has traded between a low of $10.15 and a high of $20.25. The stock has gained 43.2% over this period. It is currently 26.0% below its 52-week high.
Amarin Corporation PLC has a market capitalization of $319.13M.
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Side-by-side comparison against top Healthcare peers.